Drug Product Overview
Catalent Biologics’ drug product development and manufacturing services leverage proven expertise from pre-clinical to commercial launch and supply of biologics, biosimilars, vaccines and sterile injectables. Catalent has extensive experience with drug product process development for Phase I and II early- to mid-stage, and Catalent scientists have experience in a variety of formulations and product presentations for your drug product formulation development needs.
Whether your molecule is destined for vials (liquid or lyophilized) or syringes, Catalent’s filling lines offer the highest degree of aseptic processing and are integrated with secondary packaging in order to reliably supply your clinical or commercial product to patients.